A.P. Moller - Maersk has launched its first dedicated weekly reefer rail service connecting Hyderabad’s pharmaceutical manufacturing hub with Nhava Sheva Port near Mumbai, marking a major development for India’s temperature-sensitive export logistics sector. The service has been introduced in partnership with Container Corporation of India (CONCOR) and is designed specifically for pharmaceutical exporters requiring reliable cold-chain transportation.
The Hyderabad–Nhava Sheva corridor operates on a fixed weekly schedule using 40-foot refrigerated containers (reefers). According to Maersk, every shipment includes pre-trip inspection (PTI) compliance and quality-aligned container selection to maintain strict pharmaceutical temperature-control standards throughout transit.
The new rail-based cold-chain solution is expected to improve export reliability for India’s pharmaceutical industry, which depends heavily on uninterrupted temperature-controlled logistics for medicines, vaccines, and high-value healthcare products. Hyderabad is one of India’s largest pharmaceutical manufacturing clusters and serves multiple regulated global markets.
Under the integrated logistics model, Maersk will manage inland rail transport, ocean freight, and shipment visibility through a single-window system. The company will also provide documentation support, compliance assistance, cold-chain advisory services, and last-mile trucking at destination markets when required.
The reefer rail corridor is designed to support export cargo moving to major global markets including North America’s East Coast ports such as Newark, Norfolk, Charleston, and Savannah, along with Latin America, Europe, and other reefer trade destinations.
Maersk South Asia Managing Director Thomas Theeuwes stated that the pharmaceutical industry requires “precision, reliability, and accountability” throughout the supply chain and described the rail service as a direct response to those operational demands.
The company highlighted that rail transportation offers greater schedule stability compared to road movement, where delays are often caused by traffic congestion, driver fatigue, and compliance stoppages. The dedicated service will also provide reliable vessel loading, dedicated equipment allocation, and priority cargo handling.
A major sustainability component is also attached to the project. Based on current shipment projections, Maersk estimates that shifting cargo movement from road to rail could reduce greenhouse gas emissions by nearly 3,000 tonnes annually. The reduction supports the company’s broader Net Zero 2040 decarbonisation targets.
Sanjay Swarup said the collaboration reflects growing confidence in rail as an efficient transport mode for high-value and temperature-sensitive cargo and added that the initiative would strengthen India’s pharmaceutical export competitiveness.
The launch also reflects a broader shift in Indian supply chains toward integrated cold-chain infrastructure, multimodal transport, and lower-emission logistics solutions as pharmaceutical exports continue expanding globally.
Image Credit - www.Maersk.com
Popular Posts
Explore Topics
Comments
